KR100236853B1 - 1-(5-이소퀴놀린술포닐)호모피페라진 염산염 수화물 - Google Patents

1-(5-이소퀴놀린술포닐)호모피페라진 염산염 수화물 Download PDF

Info

Publication number
KR100236853B1
KR100236853B1 KR1019970707804A KR19970707804A KR100236853B1 KR 100236853 B1 KR100236853 B1 KR 100236853B1 KR 1019970707804 A KR1019970707804 A KR 1019970707804A KR 19970707804 A KR19970707804 A KR 19970707804A KR 100236853 B1 KR100236853 B1 KR 100236853B1
Authority
KR
South Korea
Prior art keywords
hydrochloride
isoquinolinesulfonyl
pasdil
hydrate
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019970707804A
Other languages
English (en)
Korean (ko)
Other versions
KR19990008278A (ko
Inventor
히로무 가와꾸보
마사루 오노
Original Assignee
야마모토 카즈모토
아사히 가세이 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야마모토 카즈모토, 아사히 가세이 고교 가부시키가이샤 filed Critical 야마모토 카즈모토
Publication of KR19990008278A publication Critical patent/KR19990008278A/ko
Application granted granted Critical
Publication of KR100236853B1 publication Critical patent/KR100236853B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019970707804A 1995-07-03 1996-06-19 1-(5-이소퀴놀린술포닐)호모피페라진 염산염 수화물 Expired - Fee Related KR100236853B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP95-167460 1995-07-03
JP16746095 1995-07-03

Publications (2)

Publication Number Publication Date
KR19990008278A KR19990008278A (ko) 1999-01-25
KR100236853B1 true KR100236853B1 (ko) 2000-02-01

Family

ID=15850096

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970707804A Expired - Fee Related KR100236853B1 (ko) 1995-07-03 1996-06-19 1-(5-이소퀴놀린술포닐)호모피페라진 염산염 수화물

Country Status (7)

Country Link
US (1) US5942505A (https=)
EP (1) EP0870767B1 (https=)
KR (1) KR100236853B1 (https=)
CN (1) CN1080721C (https=)
DE (1) DE69606721T2 (https=)
ES (1) ES2142065T3 (https=)
WO (1) WO1997002260A1 (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140031A (en) * 1989-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Pyranyl cyanoguanidine derivatives
CN100444843C (zh) * 1998-08-10 2008-12-24 旭化成制药株式会社 法舒地尔盐酸盐缓释口服制剂
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SE0203092D0 (en) * 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
WO2004105757A2 (en) * 2003-05-29 2004-12-09 Schering Aktiengesellschaft Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
JP4854070B2 (ja) * 2004-01-29 2012-01-11 旭化成ファーマ株式会社 バイパス術に伴う血管攣縮治療剤
CN1929847B (zh) * 2004-03-16 2011-01-19 旭化成制药株式会社 含有法舒地尔的制剂及改善其稳定性的方法
MY139797A (en) * 2004-11-29 2009-10-30 Kowa Co (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate
WO2007050783A2 (en) 2005-10-26 2007-05-03 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
CA2638802A1 (en) * 2006-01-27 2007-10-25 Translational Genomics Research Institute Genes affecting human memory performance
CN101092413B (zh) * 2006-06-23 2011-05-18 山东轩竹医药科技有限公司 法舒地尔的药用盐的水合物
WO2008019395A2 (en) * 2006-08-10 2008-02-14 Translational Genomics Research Institute Compounds for improving learning and memory
CN102002036B (zh) * 2009-08-31 2013-01-30 秦引林 一种法舒地尔的精制方法
CN102020635B (zh) * 2009-09-10 2013-04-17 河北凯盛医药科技有限公司 一种盐酸法舒地尔半水合物的制备方法
EP2332917B1 (en) 2009-11-11 2012-08-01 Sygnis Bioscience GmbH & Co. KG Compounds for PIM kinase inhibition and for treating malignancy
CN101985444B (zh) * 2010-08-20 2013-04-24 天津红日药业股份有限公司 盐酸法舒地尔的v晶型及其制备方法和用途
CN101962379B (zh) * 2010-09-28 2013-02-27 山西普德药业股份有限公司 一种磺酰基异喹啉衍生物的精制方法
CN102020636A (zh) * 2010-11-25 2011-04-20 江苏万邦生化医药股份有限公司 盐酸法舒地尔的合成及提纯方法
CN102060845B (zh) * 2010-12-28 2013-07-03 天津红日药业股份有限公司 一种法舒地尔的晶型ⅲ及其制备方法和用途
CN102225929B (zh) * 2011-05-12 2014-07-16 天津市汉康医药生物技术有限公司 一种稳定的盐酸法舒地尔水合物化合物
CN102229601B (zh) * 2011-05-12 2013-07-03 天津市汉康医药生物技术有限公司 六氢-1-(5-异喹啉磺酰基)-1(h)-1,4-二氮杂卓盐酸盐无定形化合物
US9980972B2 (en) 2012-03-12 2018-05-29 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Rho kinase inhibitors for use in treating familial amyotrophic lateral sclerosis
US8715764B2 (en) 2012-06-21 2014-05-06 Choco Finesse LLC Eutectic mixtures of esterified propoxylated glycerols with digestible fats
CN104327052A (zh) * 2014-10-20 2015-02-04 郑州四环医药用品有限公司 一种高纯度盐酸法舒地尔的制备方法
CN104945381B (zh) * 2015-06-24 2019-05-03 山东罗欣药业集团股份有限公司 一种盐酸法舒地尔化合物、其制备方法及其药物组合物
US11878023B2 (en) 2017-10-25 2024-01-23 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for delivering pharmaceutical agents
CA3120751A1 (en) 2018-12-17 2020-06-25 D. Western Therapeutics Institute, Inc. New form of isoquinoline sulfonamide
CN109776497A (zh) * 2019-03-07 2019-05-21 山东新华制药股份有限公司 一种盐酸法舒地尔半水合物的制备方法
WO2020193802A1 (en) 2019-03-28 2020-10-01 Fundación De La Comunidad Valenciana Centro De Investigación Príncipe Felipe Polymeric conjugates and uses thereof
CN113968841B (zh) * 2020-07-23 2024-05-14 合肥久诺医药科技有限公司 一种盐酸法舒地尔半水合物的制备方法
EP4422626A1 (en) 2021-10-30 2024-09-04 Aneuryst, Inc Treatments for disturbed cerebral homeostasis
EP4479035A4 (en) 2022-02-17 2026-02-25 Woolsey Pharmaceuticals Inc FASUDIL TASTE MASKING ORAL FORMULATIONS
CN118922193A (zh) 2022-02-17 2024-11-08 悟而喜制药公司 具有离子交换树脂的法舒地尔口服制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
JPS61152658A (ja) * 1984-12-27 1986-07-11 Asahi Chem Ind Co Ltd 置換されたイソキノリンスルホンアミド誘導体
JPS6293643A (ja) * 1985-10-19 1987-04-30 Fuji Photo Film Co Ltd 核酸の塩基配列決定のための信号処理方法
JP2720348B2 (ja) * 1989-03-30 1998-03-04 旭化成工業株式会社 脳細胞機能障害改善剤
JPH04278094A (ja) * 1991-03-07 1992-10-02 Asahi Chem Ind Co Ltd １−ヒドロキシ−イソキノリンスルホンアミド誘導体の製造方法
JPH05569A (ja) * 1991-06-25 1993-01-08 Kanzaki Paper Mfg Co Ltd 感熱記録体
JPH0680569A (ja) * 1992-09-03 1994-03-22 Asahi Chem Ind Co Ltd 血小板凝集阻害剤
JP3464012B2 (ja) * 1993-04-05 2003-11-05 旭化成株式会社 精神症候治療剤
JPH0741424A (ja) * 1993-07-28 1995-02-10 Asahi Chem Ind Co Ltd 抗炎症剤

Also Published As

Publication number Publication date
DE69606721D1 (de) 2000-03-23
CN1183782A (zh) 1998-06-03
CN1080721C (zh) 2002-03-13
DE69606721T2 (de) 2000-06-21
EP0870767A4 (https=) 1998-10-14
EP0870767B1 (en) 2000-02-16
EP0870767A1 (en) 1998-10-14
HK1013598A1 (en) 1999-09-03
ES2142065T3 (es) 2000-04-01
WO1997002260A1 (en) 1997-01-23
KR19990008278A (ko) 1999-01-25
US5942505A (en) 1999-08-24

Similar Documents

Publication Publication Date Title
KR100236853B1 (ko) 1-(5-이소퀴놀린술포닐)호모피페라진 염산염 수화물
RU2078079C1 (ru) Производные пирролзамещенных уреидов, и их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция, обладающая ингибирующей ангиогенезис активностью
US4294832A (en) Tetrahydroisoquinoline compounds and a pharmaceutical composition thereof
EP1535613B1 (en) Process for preparing a polymorphic form of atorvastatin calcium
KR101549876B1 (ko) 야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염
US7691894B2 (en) Cyclohexanecarboxylic acid compound
CN101573350A (zh) 甲磺酸伊马替尼的多晶型及其制备方法以及无定形和α型的甲磺酸伊马替尼
JPH09504535A (ja) 新規ベンゾイルグアニジン誘導体、その調製及び医薬組成物における使用
KR20050008692A (ko) 클로피도그렐을 함유하는 술폰산의 염 및 제약 제제를제조하기 위한 그의 용도
SK128093A3 (en) (s) (+)-2 ethoxy-4-(n-(1-(2-(n-piperidinyl)-phenyl)-3-methyl- -1-butyl) aminocarbonylmethyl) benzoic acid
US5441984A (en) Urea, thiourea and guanidine derivatives
EP1272458B1 (de) Arginin-mimetika als faktor xa-inhibitoren
JP3734531B2 (ja) １−（５−イソキノリンスルホニル）ホモピペラジン塩酸塩３水和物
EP0481756A2 (en) Benzamide derivatives
EP0193965A2 (en) Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them
US4380644A (en) 2-Oxoimidazolidine derivatives
JPH034073B2 (https=)
RU2538593C2 (ru) НОВЫЕ СТАБИЛЬНЫЕ КРИСТАЛЛЫ МОНОГИДРОХЛОРИДА 1-(2-β-D-АРАБИНОФУРАНОЗИЛ)ЦИТОЗИНА
CN116178340B (zh) 一种protac化合物、制备方法及药物组合物
BG98050A (bg) Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат
US11926586B2 (en) Process for the preparation of ferric organic compounds
JPH0971582A (ja) １−（５−イソキノリンスルホニル）ホモピペラジン塩酸塩１／２水和物
HK1013598B (en) 1-(5-isoquinolinesulfonyl)homopiperazine hydrochloride hydrates
JPH11240896A (ja) ［（ｓ）−１−［（ｓ）−２−［（トランス−４−アミノシクロヘキシルメチル）カルバモイル］ピロリジン−１−カルボニル］−２−イソプロピルチオ−２−メチルプロピル］カルバミックアシド プロピルエステルの１／２硫酸塩
JP2002542230A (ja) ５−クロロ−２−メトキシ−ｎ−（２−（４−メトキシ−３−メチルアミノチオカルボニルアミノスルホニルフェニル）エチル）ベンズアミドナトリウム塩の結晶形

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

FPAY Annual fee payment

Payment date: 20120924

Year of fee payment: 14

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 14

FPAY Annual fee payment

Payment date: 20130924

Year of fee payment: 15

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 15

FPAY Annual fee payment

Payment date: 20141001

Year of fee payment: 16

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 16

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20151006

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20151006

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000